CureBay Funding: How Much Did They Raise & Key Investors

How Much Did CureBay Raise?
Funding & Key Investors

CureBay, a prominent player in the Indian healthtech sector, has successfully secured a major strategic investment, bringing its total capital raised to $28.5M. This latest infusion of $21M underscores the company's robust growth trajectory and its critical role in bridging the healthcare accessibility gap in rural India. By leveraging a hybrid model that integrates digital platforms with physical infrastructure, CureBay continues to attract significant backing from institutional investors committed to scalable, high-impact solutions.

The recent financing round, finalized in May 2025, marks a pivotal moment for the Bhubaneswar-based firm as it transitions from its initial scaling phase toward broader market penetration. This capital injection is expected to accelerate the deployment of its eClinic network, ensuring that essential medical services reach underserved populations with greater efficiency and reliability.

What is CureBay?

CureBay

Hospitals & Physicians Clinics

Physicians Clinics

Healthcare Software

Founded in 2020, CureBay operates at the intersection of digital health and physical care delivery. The company addresses the systemic challenges of healthcare access in rural regions by deploying a comprehensive ecosystem that includes doctor consultations, diagnostic services, pharmacy fulfillment, and specialized referral pathways. By utilizing a hybrid eClinic model, CureBay effectively lowers the barrier to entry for quality medical care, positioning itself as a vital infrastructure provider in the evolving Indian healthcare landscape. Its market position is defined by its ability to combine technological agility with localized, physical touchpoints, creating a sustainable and scalable framework for rural health management.

How much funding has CureBay raised?

CureBay has raised a total of $28.5M across 2 funding rounds:

2024

Series A

$7.5M

2025

Other Financing Round

$21M

Series A (2024): $7.5M with participation from Elevar Equity

Other Financing Round (2025): $21M led by Elevar Equity and Bertelsmann SE

Key Investors in CureBay

Elevar Equity

Elevar Equity is a venture capital firm focused on early growth capital for entrepreneurs building inclusive, affordable, and scalable solutions for underserved communities.

Bertelsmann SE

Bertelsmann is a global media and services conglomerate that operates an international network of funds, focusing on strategic investments across diverse sectors including education and digital services.

What's next for CureBay?

With the recent influx of capital, CureBay is well-positioned to scale its operations significantly. The strategic roadmap likely involves expanding its footprint of eClinics into new geographies and enhancing its digital platform capabilities to support a higher volume of patient interactions. As the company matures, the focus will shift toward optimizing operational efficiencies and deepening its integration with local healthcare providers. This major enterprise-level funding provides the necessary runway to solidify CureBay's market leadership, potentially setting the stage for future expansion or strategic partnerships within the broader healthtech ecosystem.

See full CureBay company page

See More Financial Insights